P3 Health Partners Inc.
PIII
$8.94
-$0.56-5.90%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.36% | -4.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.36% | -4.49% | |||
| Cost of Revenue | 2.07% | 10.06% | |||
| Gross Profit | 0.65% | -384.54% | |||
| SG&A Expenses | -5.14% | 24.16% | |||
| Depreciation & Amortization | -2.40% | -0.09% | |||
| Other Operating Expenses | 108.76% | 634.82% | |||
| Total Operating Expenses | 5.43% | 15.79% | |||
| Operating Income | -15.24% | -261.24% | |||
| Income Before Tax | -16.67% | -282.85% | |||
| Income Tax Expenses | 237.36% | -472.42% | |||
| Earnings from Continuing Operations | -25.57% | -257.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 25.19% | 236.27% | |||
| Net Income | -26.03% | -286.96% | |||
| EBIT | -15.24% | -261.24% | |||
| EBITDA | -19.42% | -849.25% | |||
| EPS Basic | -75.01% | -226.51% | |||
| Normalized Basic EPS | -2.19% | -1,800.31% | |||
| EPS Diluted | -85.00% | -112.96% | |||
| Normalized Diluted EPS | -3.98% | -1,829.45% | |||
| Average Basic Shares Outstanding | -27.98% | 18.51% | |||
| Average Diluted Shares Outstanding | -29.21% | 16.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||